John Katzenellenbogen
Corporate Officer/Principal presso University of Illinois
Posizioni attive di John Katzenellenbogen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of Illinois | Corporate Officer/Principal | - | - |
Storia della carriera di John Katzenellenbogen
Precedenti posizioni note di John Katzenellenbogen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| RADIUS HEALTH, INC. | Fondatore | 03/10/2003 | - |
| Corporate Officer/Principal | 03/10/2003 | - |
Formazione di John Katzenellenbogen
| Harvard University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Corporate Officer/Principal | 2 |
| Founder | 1 |
| Doctorate Degree | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
